Particle News: Latest MAPS Public Benefit Corporation news

FDA Rejects MDMA-Assisted Therapy for PTSD, Citing Insufficient Evidence

Lykos Therapeutics faces major setbacks as it plans additional trials to meet FDA requirements for approval.

FDA Declines MDMA for PTSD Treatment, Requests Further Trials

FDA Rejects MDMA for PTSD Treatment, Requests More Trials

FDA Rejects MDMA for PTSD Treatment, Citing Data Concerns

FDA Panel Rejects MDMA for PTSD Treatment Over Data Concerns

FDA Panel Recommends Against MDMA-Assisted Therapy for PTSD

FDA Panel to Review MDMA Therapy for PTSD

FDA Reviews MDMA-Assisted Therapy for PTSD as Congress Pushes Psychedelic Research